Pathological physiology of complications of Eisenmenger syndrome
Authors:
Company:
1 Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation
2 Russian State Medical Postgraduate Academy, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Reviews
DOI:
For citation: Shmalts A.A., Kupryashov A.A., Chernogrivov I.E. Pathological physiology of complications of Eisenmenger syndrome. Creative Cardiology. 2024; 18 (1): 7–19 (in Russ.). DOI: 10.24022/1997-3187-2024-18-1-7-19
Received / Accepted: 29.01.2024 / 12.02.2024
Keywords: Eisenmenger syndrome congenital heart defects pathological physiology
Abstract
Eisenmenger syndrome (ES) is systemic pulmonary hypertension with venoarterial or bidirectional shunting of blood between the ventricles, atria or great arteries due to the progression of pulmonary vascular disease in the natural course of “simple” and “complex” congenital heart defects. Central cyanosis and chronic hypoxemia lead to damage to many organs and systems – secondary erythrocytosis (often with iron deficiency), blood clotting disorders with thrombosis and bleeding, paradoxical embolism, renal dysfunction, gout, cholelithiasis and fibrotic changes in the liver, diffuse brain damage, hypertrophic osteoarthropathy with scoliosis and deformation of the distal phalanges of the fingers, increasing the risk of arrhythmias, infectious and other complications. The review focuses on pathological physiology, including cardiac function, and prognosis in patients with ES.References
- Eisenmenger V. Die angeborenen Defecte der Kammerscheidewand des Herzens. Z. Klin. Med. 1897; 32 (Suppl.): 1–28.
- Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br. Med. J. 1958; 2 (5099): 755–762. DOI: 10.1136/bmj.2.5099.755
- Chaix M.A., Gatzoulis M.A., Diller G.P., Khairy P., Oechslin E.N. Eisenmenger syndrome: a multisystem disorder-do not destabilize the balanced but fragile physiology. Can. J. Cardiol. 2019; 35 (12): 1664–1674. DOI: 10.1016/j.cjca.2019.10.002
- Barradas-Pires A., Constantine A., Dimopoulos K. Preventing disease progression in Eisenmenger syndrome. Expert. Rev. Cardiovasc. Ther. 2021; 19 (6): 501–518. DOI: 10.1080/14779072.2021.1917995
- Arvanitaki A., Gatzoulis M.A., Opotowsky A.R., Khairy P., Dimopoulos K., Diller G.P. et al. Eisenmenger syndrome: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2022; 79 (12): 1183–1198. DOI: 10.1016/j.jacc.2022.01.022
- Diller G.P., Lammers A.E., Oechslin E. Treatment of adults with Eisenmenger syndrome-state of the art in the 21st century: a short overview. Cardiovasc. Diagn. Ther. 2021; 11 (4): 1190–1199. DOI: 10.21037/cdt-21-135
- Dimopoulos K., Diller G.P. (Eds.) Pulmonary hypertension in adult congenital heart disease. Springer; 2017: 29–44. DOI: 10.1007/978-3-319-46028-4
- Kaemmerer H., Niwa K., Oechslin E., Ewert P., Webb G.D., Hess J. Pulmonary arterial hypertension in congenital heart disease: Eisenmenger's syndrome – а global perspective. 1st ed. Bremen: UNI-MED; 2013.
- Baskar S., Horne P., Fitzsimmons S., Khoury P.R., Vettukattill J., Niwa K. et al. Arrhythmia burden and related outcomes in Eisenmenger syndrome. Congenit. Heart Dis. 2017; 12 (4): 512–519. DOI: 10.1111/chd.12481
- Opotowsky A.R., Landzberg M.J., Beghetti M. The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. Heart Fail. Clin. 2014; 10 (1): 91–104. DOI: 10.1016/j.hfc.2013.09.005
- Barnea O., Austin E.H., Richman B., Santamore W.P. Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 1994; 24 (5): 1376–1381. DOI: 10.1016/0735-1097(94)90123-6
- Broberg C.S., Bax B.E., Okonko D.O., Rampling M.W., Bayne S., Harries C. et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J. Am. Coll. Cardiol. 2006; 48 (2): 356–365. DOI: 10.1016/j.jacc.2006.03.040
- Dimopoulos K., Wort S.J., Gatzoulis M.A. Pulmonary hypertension related to congenital heart disease: a call for action. Eur. Heart J. 2014; 35 (11): 691–700. DOI: 10.1093/eurheartj/eht437
- Gorbachevsky S.V., Shmalts A.A. Primary examination. In: Gorbachevsky S.V., Shmalts A.A. (Eds.) Diagnosis of pulmonary hypertension in congenital heart defects. Moscow; 2023 (in Russ.).
- Gorbachevsky S.V., Shmalts A.A., Plotnikova L.R. Pulmonary hypertension in children with congenital heart defects. Moscow; 2018 (in Russ.).
- Kupryashov A.A., Rivnyak M.I. Hypoxia and iron deficiency: synergistic effects on the body. Clinical Physiology of Circulation. 2022; 19 (1): 57–69 (in Russ.). DOI: 10.24022/1814-6910- 2022-19-1-57-69
- Larici A.R., Franchi P., Occhipinti M., Contegiacomo A., del Ciello A., Calandriello L. et al. Diagnosis and management of hemoptysis. Diagn. Interv. Radiol. 2014; 20 (4): 299–309. DOI: 10.5152/dir.2014.13426
- Kamada K., Hosokawa K., Inoue K., Abe K. A 'Mille-Feuille'- like giant dissecting aneurysm of the pulmonary artery in Eisenmenger syndrome. Eur. Heart J. 2021; 42 (1): 137. DOI: 10.1093/eurheartj/ehaa513
- Chen K., Jiang P. Brain abscess associated with ventricular septal defect and Eisenmenger syndrome: a case report. Int. J. Surg. Case Rep. 2021; 81: 105799. DOI: 10.1016/j.ijscr.2021.105799
- Cool C.J., Fathini F., Adams I., Saboe A., Kusumawardhani N.Y., Astuti A., Yahya A.F. Eisenmenger syndrome with left main compression syndrome: a case report. BMC. Cardiovasc. Disord. 2022; 22 (1): 89. DOI: 10.1186/s12872-022-02524-w
- Oechslin E., Kiowski W., Schindler R., Bernheim A., Julius B., Brunner-La Rocca H.P. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation. 2005; 112 (8): 1106–1112. DOI: 10.1161/CIRCULATIONAHA.105.534073
- Diller G.P., Dimopoulos K., Broberg C.S., Kaya M.G., Naghotra U.S., Uebing A. et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur. Heart J. 2006; 27 (14): 1737–1742. DOI: 10.1093/eurheartj/ehl116
- Perloff J., Child J., Aboulhosn J. Cyanotic congenital heart disease: а multisystem disorder. Congenital heart disease in adults. 3rd ed. Philadelphia (РА): Saunders; 2008.
- Jensen A.S., Johansson P.I., Idorn L., Sørensen K.E., Thilén U., Nagy E. et al. The haematocrit – an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease. Int. J. Cardiol. 2013; 167 (4): 1317–1321. DOI: 10.1016/j.ijcard.2012.03.181
- Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int. J. Cardiol. 2004; 97 (Suppl. 1): 109–115. DOI: 10.1016/j.ijcard.2004.08.015
- Broberg C.S., Jayaweera A.R., Diller G.P., Prasad S.K., Thein S.L., Bax B.E. et al. Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease. Am. J. Cardiol. 2011; 107 (4): 595–599. DOI: 10.1016/j.amjcard.2010.10.019
- Tay E.L., Peset A., Papaphylactou M., Inuzuka R., AlonsoGonzalez R., Giannakoulas G. et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int. J. Cardiol. 2011; 151 (3): 307–312. DOI: 10.1016/j.ijcard.2010.05.066
- Westbury S.K., Lee K., Reilly-Stitt C., Tulloh R., Mumford A.D. High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry. Thromb. Res. 2013; 132 (2): e145–151. DOI: 10.1016/j. thromres.2013.07.006
- Lill M.C., Perloff J.K., Child J.S. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am. J. Cardiol. 2006; 98 (2): 254–258. DOI: 10.1016/j.amjcard.2006.01.083
- Baroutidou A., Arvanitaki A., Hatzidakis A., Pitsiou G., Ziakas A., Karvounis H. et al. Haemoptysis in pulmonary arterial hypertension associated with congenital heart disease: insights on pathophysiology, diagnosis and management. J. Clin. Med. 2022; 11 (3): 633. DOI: 10.3390/jcm11030633
- Hjortshøj C.M.S., Kempny A., Jensen A.S., Sørensen K., Nagy E., Dellborg M. et al. Past and current cause-specific mortality in Eisenmenger syndrome. Eur. Heart J. 2017; 38 (26): 2060–2067. DOI: 10.1093/eurheartj/ehx201
- Jensen A.S., Idorn L., Thomsen C., von der Recke P., Mortensen J., Sørensen K.E. et al. Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease. Heart. 2015; 101 (19): 1540–1546. DOI: 10.1136/heartjnl2015-307657
- Martin-Garcia A.C., Arachchillage D.R., Kempny A., AlonsoGonzalez R., Martin-Garcia A., Uebing A. et al. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. Heart. 2018; 104 (1): 45–50. DOI: 10.1136/heartjnl-2016-311144
- Arvanitaki A., Giannakoulas G., Triantafyllidou E., Feloukidis C., Boutou A., Garyfallos A. et al. Peripheral microangiopathy in Eisenmenger syndrome: a nailfold video capillaroscopy study. Int. J. Cardiol. 2021; 336: 54–59. DOI: 10.1016/j.ijcard.2021.03.033
- Dimopoulos K., Diller G.P., Koltsida E., Pijuan-Domenech A., Papadopoulou S.A., Babu-Narayan S.V. et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008; 117 (18): 2320–2328. DOI: 10.1161/CIRCULATIONAHA.107.734921
- Oya H., Nagaya N., Satoh T., Sakamaki F., Kyotani S., Fujita M. et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart. 2000; 84 (1): 53–58. DOI: 10.1136/heart.84.1.53
- Arivazhagan S., Kadhiravan T., Basu D., Dutta T.K. Validation of the megakaryocyte fragmentation theory of finger clubbing in patients with cardiopulmonary diseases. Platelets. 2014; 25 (5): 317–321. DOI: 10.3109/09537104.2013.821605
- Kaur C., Ling E.A. Blood brain barrier in hypoxic-ischemic conditions. Curr. Neurovasc. Res. 2008; 5 (1): 71–81. DOI: 10.2174/156720208783565645
- Kalogeropoulos A.P., Border W.L., Georgiopoulou V.V., Pernetz M.A., Howell S., McConnell M. et al. Right ventricular function in adult patients with Eisenmenger physiology: insights from quantitative echocardiography. Echocardiography. 2010; 27 (8): 937–945. DOI: 10.1111/j.1540-8175.2010.01194.x
- Hopkins W.E., Waggoner A.D. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am. J. Cardiol. 2002; 89 (1): 34–38. DOI: 10.1016/s0002-9149(01)02159-2
- Kopeć G., Moertl D., Miszalski-Jamka T., Waligóra M., Tyrka A., Sarnecka A., Podolec P. Left ventricular mass is preserved in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Heart Lung Circ. 2014; 23 (5): 454–461. DOI: 10.1016/j.hlc.2013.12.002
- Baryshnikova I.Yu., Shmalts A.A. Echocardiography. In: Gorbachevsky S.V., Shmalts A.A. (Eds.) Diagnosis of pulmonary hypertension in congenital heart defects. Moscow; 2023 (in Russ.).
- Moceri P., Kempny A., Liodakis E., Alonso Gonzales R., Germanakis I., Diller G.P. et al. Physiological differences between various types of Eisenmenger syndrome and relation to outcome. Int. J. Cardiol. 2015; 179: 455–460. DOI: 10.1016/j.ijcard.2014.11.100
- Gong C., Guo J., Wan K., Wang L., Chen X., Guo J. et al. Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping. J. Cardiovasc. Magn. Reson. 2022; 24 (1): 60. DOI: 10.1186/s12968-022-00880-2
- Perloff J.K. The coronary circulation in cyanotic congenital heart disease. Int. J. Cardiol. 2004; 97 (Suppl. 1): 79–86. DOI: 10.1016/j.ijcard.2004.08.018
- Gupta A., Patel C., Gupta S.K., Ramakrishnan S., Saxena A., Kothari S.S. Myocardial perfusion abnormalities in Eisenmenger syndrome. Nucl. Med. Commun. 2020; 41 (3): 206–211. DOI: 10.1097/MNM.0000000000001147
- Van Wolferen S.A., Marcus J.T., Westerhof N., Spreeuwenberg M.D., Marques K.M., Bronzwaer J.G. et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur. Heart J. 2008; 29 (1): 120–127. DOI: 10.1093/eurheartj/ehm567
- Diller G.P., Dimopoulos K., Okonko D., Li W., Babu-Narayan S.V., Broberg C.S. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112 (6): 828–835. DOI: 10.1161/CIRCULATIONAHA.104.529800
- Shmalts A.A., Gorbachevsky S.V. Evidence base for specific pulmonary vasodilators in adults with congenital heart disease. Therapeutic Archive. 2021; 93 (9): 1106–1116 (in Russ.). DOI: 10.26442/00403660.2021.09.201022
- An H.S., Kim G.B., Song M.K., Bang J.S., Lee S.Y., Bae E.J., Noh C.I. Eisenmenger syndrome in adults: treatment pattern and prognostic factors in the advanced pulmonary vasodilator era. Pediatr. Cardiol. 2019; 40 (1): 23–28. DOI: 10.1007/s00246-018-1956-y
- Kempny A., Hjortshøj C.S., Gu H., Li W., Opotowsky A.R., Landzberg M.J. et al. Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study. Circulation. 2017; 135 (15): 1432–1440. DOI: 10.1161/CIRCULATIONAHA.116.023033
- Chiriac A., Riley D.C., Russell M., Moore J.P., Padmanabhan D., Hodge D.O. et al. Determinants of sudden cardiac death in adult patients with Eisenmenger syndrome. J. Am. Heart Assoc. 2020; 9 (6): e014554. DOI: 10.1161/JAHA.119.014554